Nocturia Nocturia
Conditions
Interventions
None listed
Sponsors
Mikawa Yasuhito
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women aged 20 to 80 years old 2) Patients with nocturia (defined as waking up to urinate more than twice during sleep) 3) Patients for whom standard medications have not been effective 4) Cases deemed appropriate by the principal investigator or co-investigator
Exclusion criteria
Exclusion criteria: A. Exclusions due to medical history, concomitant use, or physician's discretion 1. Patients who had a hypersensitivity or allergic reaction to CBD or CBG preparations and were unable to continue the study. 2. Patients taking other medications concomitantly. 3. Patients who have previously participated in clinical trials and have not yet taken the study drug for more than one month. 4. Patients who the principal investigator or co-investigator deems inappropriate for inclusion. B. Exclusions due to underlying diseases or physical conditions 5. Severe liver damage 6. Cardiac dysfunction 7. Renal dysfunction 8. Pregnant 9. Breastfeeding 10. Symptomatic urinary tract infection 11. Diabetes 12. Cancer 13. Multiple sclerosis, spinal cord injury, or Parkinson's disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief of nocturia (for patients who urinate more than twice a night) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of mild dementia, disorientation, taste disorders, insomnia, sleep disorders, fatigue, high blood pressure, and urination volume | — |
Contacts
Public ContactHideo Kobayashi
JSCSF Japan Society of Clinical Study for Frontier-Medicine
Outcome results
None listed